Blog

Even though the protocol for dosing insulin can be carefully calculated for the particular patient in need, what if that patient’s need for insulin changes quickly after the initial dose recommendation? This concept is not only unheard of, it is very common. Based on a wide range of factors, such as a patient’s activity level, meals consumed, and stress, a...

Kidneys can be injured by a number of reasons. In the United States alone, more than 26 million people are estimated to have chronic kidney disease (CKD), although most don’t know it because early signs are often missed. “While diabetes is the leading cause of kidney failure that does not mean that everyone with diabetes will develop CKD severe enough...

This past Wednesday, the team at Monarch Medical Technologies announced ground-breaking EREI technology for any hospital scenario where intravenous insulin is administered. Dr. Patrick Burgess, founder and inventor of EndoTool, described the technology as having the potential to nearly eliminate severe hypoglycemia while removing the risk of human oversight. EREI refers to “estimated residual extracellular insulin” present in a patient’s...

Estimated residual extracellular insulin, or EREI, refers to residual insulin present in a patient’s body. Every patient receiving insulin therapy requires personalized treatment based on their individual makeup. In addition to this, each patient’s need for insulin is not only different, but, ever-changing based on activity level, meals consumed and stress. The amount of residual insulin present in a person’s...

While dosing protocols may be carefully calculated, a hospitalized patient’s need for insulin may change quickly based on a wide range of factors. Insulin therapy must follow suit. Compared to paper protocols and lookup tables, computerized insulin management solutions enhance ease of use and accuracy. However, many computerized systems rely on the same imprecise protocols as manual methods and fall...